Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
The roles of biomarkers in Alzheimer's disease clinical trials.
Jeffrey Cummings, Shailja Sharma, G Andrea, Amanda Leisgang Osse, Andrew Ortiz
Published: 202510.1016/j.neurot.2025.e00811
Abstract
Biomarkers are essential to guide decision making in Alzheimer's disease (AD) clinical trials where they have a variety of contexts of use (COUs) including diagnosis, risk, pharmacodynamic response, prognosis, prediction, monitoring, and safety. The…
Preview only. Read the full abstract at the source